Buscar
Congreso SOLACI
HomeInternational CongressesACC 2017

ACC 2017

Ver Categoría
ACC 2017 HIGHLIGHTS

Closing off the Appendage While Performing Cardiac Surgery Results in a Reduction in Risk of Embolic Stroke

Closing off the left appendage as an add-on procedure while performing other cardiac surgery in patients with...
solaci -
Ver más
ACC 2017 HIGHLIGHTS

Infarction in Cariogenic Shock: Prioritizing the Use of Impella Could Improve Survival

This small study suggests the early use of Impella ventricular support device in patients undergoing AMI complicated...
solaci -
Ver más
ACC 2017 HIGHLIGHTS

FFR-Guided ACS Revascularization Apparently Superior to Culprit Vessel Treatment

Using fractional flow reserve (FFR) to guide revascularization of all functionally significant lesions in the setting of...
solaci -
Ver más
ACC 2017 HIGHLIGHTS

Higher Radiation Dose in Patients and Operators with Radial Approach (RAD-MATRIX Dosimeter)

Both physicians and patients are exposed to higher radiation doses during radial access PCI compared to femoral,...
solaci -
Ver más
ACC 2017 HIGHLIGHTS

DECISION-CTO: Prevailing Questions on CTO Rechanneling

The first and only randomized trial on chronic total occlusion (CTO) revascularization versus optimal medical therapy in...
solaci -
Ver más
ACC 2017 HIGHLIGHTS

ABSORB III: More Events with Absorb Than With Xience at Two Years

The two year outcomes of ABSORB III, presented at the scientific sessions of the American College of...
solaci -
Ver más
ACC 2017 HIGHLIGHTS

Surgery or TAVR in intermediate risk? Results of the SURTAVI Study

Courtesy of Dr. Gustavo Leiva. Transcatheter aortic-valve replacement (TAVR) with the use of a self-expanding prosthesis is superior...
solaci -
Ver más
ACC 2017

ACC 2017

Here you will find the highlights of ACC 2017, held on March 17-19 in Washington DC, USA. If...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

TCT 2024 | FAVOR III EUROPA

Dr. Carlos Fava - 0
The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

Dr. Carlos Fava - 0
This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Dr. Omar Tupayachi - 0
Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

Noticias Institucionales

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Arequipa Sessions 2024: Meet the International Guests

solaci - 0
The Arequipa Sessions 2024 is getting closer and closer. Meet the international guests who will share their knowledge for 2 days at a high-level...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad